Astrana Health, Inc. (ASTH)
(Delayed Data from NSDQ)
$38.89 USD
-0.16 (-0.41%)
Updated May 10, 2024 04:00 PM ET
After-Market: $38.95 +0.06 (0.15%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Astrana Health, Inc. (ASTH) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$50.00 | $60.00 | $44.00 | 28.57% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Astrana Health, Inc. comes to $50.00. The forecasts range from a low of $44.00 to a high of $60.00. The average price target represents an increase of 28.57% from the last closing price of $38.89.
Analyst Price Targets (6 )
Broker Rating
Astrana Health, Inc. currently has an average brokerage recommendation (ABR) of 1.29 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 1.29 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, six are Strong Buy, representing 85.71% of all recommendations. A month ago, Strong Buy represented 85.71%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 6 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.29 | 1.29 | 1.29 | 1.29 | 1.67 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/8/2024 | Lake Street Capital Markets | Brooks G O'Neil | Strong Buy | Strong Buy |
5/7/2024 | William Blair | Ryan S Daniels | Strong Buy | Strong Buy |
3/1/2024 | Truist Securities | Jailendra Singh | Hold | Hold |
1/2/2024 | BTIG | David M Larsen | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.29 |
ABR (Last week) | 1.29 |
# of Recs in ABR | 7 |
Average Target Price | $50.00 |
LT Growth Rate | 18.00% |
Industry | Medical - Outpatient and Home Healthcare |
Industry Rank by ABR | 68 of 252 |
Current Quarter EPS Est: | 0.43 |